These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 11074884

  • 1. Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study.
    Partensky C, Sassolas G, Henry L, Paliard P, Maddern GJ.
    Arch Surg; 2000 Nov; 135(11):1298-300. PubMed ID: 11074884
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY, Lai EC, Leung TW, Yu SC.
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [Abstract] [Full Text] [Related]

  • 3. Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates.
    Keng GH, Sundram FX, Yu SW, Somanesan S, Premaraj J, Oon CJ, Kwok R, Htoo MM.
    Ann Acad Med Singap; 2002 May; 31(3):382-6. PubMed ID: 12061301
    [Abstract] [Full Text] [Related]

  • 4. The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: a pilot study.
    Brans B, De Winter F, Defreyne L, Troisi R, Vanlangenhove P, Van Vlierberghe H, Lambert B, Praet M, de Hemptinne B, Dierckx RA.
    Cancer Biother Radiopharm; 2001 Aug; 16(4):333-8. PubMed ID: 11603004
    [Abstract] [Full Text] [Related]

  • 5. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M, Vigano' L, Ferrero A, Pellerito R, Carbonatto P, Capussotti L.
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [Abstract] [Full Text] [Related]

  • 6. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
    Boucher E, Garin E, Guylligomarc'h A, Olivié D, Boudjema K, Raoul JL.
    Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
    [Abstract] [Full Text] [Related]

  • 7. Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma.
    Raoul JL, Guyader D, Bretagne JF, Heautot JF, Duvauferrier R, Bourguet P, Bekhechi D, Deugnier YM, Gosselin M.
    Hepatology; 1997 Nov; 26(5):1156-61. PubMed ID: 9362356
    [Abstract] [Full Text] [Related]

  • 8. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
    Chen MS, Li JQ, Zhang YQ, Lu LX, Zhang WZ, Yuan YF, Guo YP, Lin XJ, Li GH.
    World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
    [Abstract] [Full Text] [Related]

  • 9. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.
    Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, Chan AT, Yeo W, Mok TS, Yu SC, Leung NW, Johnson PJ.
    Lancet; 1999 Mar 06; 353(9155):797-801. PubMed ID: 10459961
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
    Boucher E, Bouguen G, Garin E, Guillygomarch A, Boudjema K, Raoul JL.
    J Nucl Med; 2008 Mar 06; 49(3):362-6. PubMed ID: 18287267
    [Abstract] [Full Text] [Related]

  • 11. Superselective intra-arterial radiometabolic therapy with I-131 lipiodol in hepatocellular carcinoma.
    Maini CL, Scelsa MG, Fiumara C, Tofani A, Sciuto R, Tipaldi L, D'Annibale M, Santoro E.
    Clin Nucl Med; 1996 Mar 06; 21(3):221-6. PubMed ID: 8846568
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant Intraarterial Lipiodol or ¹³¹I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial.
    Dumortier J, Decullier E, Hilleret MN, Bin-Dorel S, Valette PJ, Boillot O, Partensky C, Letoublon C, Ducerf C, Leroy V, Vuillez JP, Borson-Chazot F.
    J Nucl Med; 2014 Jun 06; 55(6):877-83. PubMed ID: 24722530
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma.
    Boucher E, Corbinais S, Rolland Y, Bourguet P, Guyader D, Boudjema K, Meunier B, Raoul JL.
    Hepatology; 2003 Nov 06; 38(5):1237-41. PubMed ID: 14578862
    [Abstract] [Full Text] [Related]

  • 14. Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma.
    Leung WT, Lau WY, Ho S, Chan M, Leung N, Lin J, Ho KC, Metreweli C, Johnson PJ, Li AK.
    J Nucl Med; 1994 Aug 06; 35(8):1313-8. PubMed ID: 7519259
    [Abstract] [Full Text] [Related]

  • 15. Epirubicin-Lipiodol chemotherapy versus 131iodine-Lipiodol radiotherapy in the treatment of unresectable hepatocellular carcinoma.
    Bhattacharya S, Novell JR, Dusheiko GM, Hilson AJ, Dick R, Hobbs KE.
    Cancer; 1995 Dec 01; 76(11):2202-10. PubMed ID: 8635022
    [Abstract] [Full Text] [Related]

  • 16. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
    Izumi R, Shimizu K, Iyobe T, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I.
    Hepatology; 1994 Aug 01; 20(2):295-301. PubMed ID: 8045490
    [Abstract] [Full Text] [Related]

  • 17. Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma: a comparative analysis.
    Chua TC, Saxena A, Chu F, Butler SP, Quinn RJ, Glenn D, Morris DL.
    Int J Clin Oncol; 2011 Apr 01; 16(2):125-32. PubMed ID: 21061140
    [Abstract] [Full Text] [Related]

  • 18. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K, Shimada H, Togo S, Takahashi T, Endo I, Sekido H, Yoshida T.
    Hepatogastroenterology; 1999 Apr 01; 46(26):1083-8. PubMed ID: 10370671
    [Abstract] [Full Text] [Related]

  • 19. Randomized controlled trial to compare the dose of adjuvant chemotherapy after curative resection of hepatocellular carcinoma.
    Kwok PC, Lam TW, Lam PW, Tang KW, Chan SC, Hwang JS, Cheung MT, Tang DL, Chung TK, Chia NH, Wong WK, Chan MK, Lo HY, Lam WM.
    J Gastroenterol Hepatol; 2003 Apr 01; 18(4):450-5. PubMed ID: 12653895
    [Abstract] [Full Text] [Related]

  • 20. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol.
    Raoul JL, Messner M, Boucher E, Bretagne JF, Campion JP, Boudjema K.
    Br J Surg; 2003 Nov 01; 90(11):1379-83. PubMed ID: 14598418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.